Mbx Biosciences Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Mbx Biosciences Inc (MBX) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
API endpoints for this dataset
Mbx Biosciences Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Mbx Biosciences Inc | - | - | - | Yes |
| High-Confidence Competitors (1) | ||||
| Similar-Size Competitors (10) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
MBX Stock Performance relative to its Competitors
MBX Stock Performance relative to High-Confidence Competitors
MBX Stock Performance relative to Similar-Size Competitors
Mbx Biosciences Inc's Comment on Competition and Industry Peers
Mbx Biosciences Inc's Competitors Named by the Company
Competitive relationships identified from Mbx Biosciences Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Bridgebio Pharma Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Mbx Biosciences Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
